CloudMD Software & Services (OTCMKTS:DOCRF) and Pro Medicus (OTCMKTS:PMCUF) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation.
Analyst Recommendations
This is a summary of recent ratings and price targets for CloudMD Software & Services and Pro Medicus, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
CloudMD Software & Services | 0 | 0 | 2 | 0 | 3.00 |
Pro Medicus | 0 | 1 | 2 | 0 | 2.67 |
CloudMD Software & Services currently has a consensus price target of $3.3750, indicating a potential upside of 110.28%. Given CloudMD Software & Services' stronger consensus rating and higher possible upside, equities research analysts plainly believe CloudMD Software & Services is more favorable than Pro Medicus.
Earnings and Valuation
This table compares CloudMD Software & Services and Pro Medicus' gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
CloudMD Software & Services | N/A | N/A | N/A | N/A | N/A |
Pro Medicus | N/A | N/A | N/A | N/A | N/A |
Profitability
This table compares CloudMD Software & Services and Pro Medicus' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
CloudMD Software & Services | N/A | N/A | N/A |
Pro Medicus | N/A | N/A | N/A |
Summary
CloudMD Software & Services beats Pro Medicus on 2 of the 2 factors compared between the two stocks.